Filter your results
- 2
- 1
- 2
- 1
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Anti-Porphyromonas gingivalis antibodies titres are associated with non-smoking status in early rheumatoid arthritis: Results from the ESPOIR cohortArthritis & rheumatology, 2015, 67 (7), pp.1729-1737. ⟨10.1002/art.39118⟩
Journal articles
hal-01188854v1
|
||
Analysis of anti Porphyromonas gingivalis (P. gingivalis) antibodies in a large cohort of patients with an early arthritis (ESPOIR)EULAR 2013 congress, 2013, France
Conference papers
inserm-00801262v1
|
|||
|
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusAutoimmunity Reviews, 2017, 16 (6), pp.650-657. ⟨10.1016/j.autrev.2017.04.011⟩
Journal articles
hal-01787368v1
|